EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Go Watanabe
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuda, T.
Right arrow Articles by Watanabe, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, T.
Right arrow Articles by Watanabe, G.
Related Collections
Right arrow Myocardial protection

Eur J Cardiothorac Surg 2001;19:647-652
© 2001 Elsevier Science NL

Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart

Tamotsu Yasuda, Hiroyuki Kamiya, Yoko Tanaka, Go Watanabe

Department of Surgery (I), Kanazawa University School of Medicine, Takaramachi 13-1, Kanazawa 920-8641, Japan

Received 18 December 2000; received in revised form 16 February 2001; accepted 28 February 2001.

Corresponding author. Tel.: +81-76-265-2356; fax: +81-76-222-6833
e-mail: yasuda717{at}nyc.odn.ne.jp

Objectives: We sought to test the effectiveness of ultra-short-acting cardioselective beta-blockade, landiolol hydrochloride, for warm heart surgery. Methods: The isolated perfused rat heart preparation was used. After preischemic measurement of cardiac function, 3 min of coronary infusion of crystalloid cardioplegic solution (37°C) with landiolol hydrochloride of various concentrations (1, 2.5, 5, and 10 mmol/l) or without it (control group) was performed, followed by 30 min of warm ischemic arrest. Finally, postischemic function was measured. Results: The percentage recoveries of heart rate in hearts receiving 0, 1, 2.5, 5, and 10 mmol/l landiolol hydrochloride were 89.4±3.4%, 90.9±1.7%, 89.6±1.8%, 83.4±3.3%, and 74.3±1.9% (P<0.05 vs. 0, 1, and 2.5 mmol/l groups), respectively. The percentage recoveries of aortic flow were 55.6±3.1%, 62.8±3.3%, 75.0±4.2% (P<0.05 vs. 0 and 10 mmol/l groups), 65.3±5.3%, and 51.6±4.0%, respectively. Similar recovery profiles were observed with the first derivative of the rise in aortic pressure, stroke volume and stroke work. The total amount of coronary effluent in the hearts receiving 5 or 10 mmol/l was lower than in the other groups. Conclusions: Landiolol hydrochloride has the potential to enhance postischemic cardiac function after the warm cardioplegic arrest. The optimal concentration for maximum postischemic functional recovery was 2.5 mmol/l, and recoveries of aortic flow and heart rate decreased in hearts receiving 5 mmol/l or more.

Key Words: Beta-blockade • Myocardial protection • Warm heart surgery




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. Mieno, H. Horimoto, K. Kishida, S. Horimoto, and S. Sasaki
Landiolol Enhances Effect of Ischemic Preconditioning in Isolated Rabbit Hearts
Asian Cardiovasc Thorac Ann, June 1, 2006; 14(3): 239 - 243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.